Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
1418013-75-8
It accelerated FRAP recovery at 1 µM and no significant cytotoxicity up to 50 μM in U2OS cells
Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently
and the p70S6K target S6RP are also observed in PTEN-deficient MES-SA human uterine tumor xenografts after treatment with 40 and 50 mg/kg p
BSJ-03-123 rescein Diacetate 1418013-75-8BSJ 03 123 is a Selective Cdk6 degrader. BSJ 03 123 exploits protein interface determinants to achieve proteome wide selectivity for the degradation of cyclin dependent kinase 6 (CDK6). Pharmacologic CDK6 degradation targets a selective dependency of acute myeloid leukemia cells, and transcriptomics and phosphoproteomics profiling of acute degradation of CDK6 enabled dynamic mapping of its immediate role in coordinating signaling and transcription.
US$ 1486.50
US$ 1926.00
US$ 30.00
US$ 44.95
US$ 112.50
US$ 2477.00
US$ 1917.00
US$ 939.50
US$ 1329.00